Skip to main content
HeartCited

Chitosan 관련 고지혈증(이상지질혈증)

C 근거 소규모 연구에서의 근거는 제한적이지만, 일부 긍정적인 신호가 존재합니다.

Cochrane review of 14 RCTs: modest total cholesterol reduction (6-14 mg/dL). Clinical significance is debated. Fat-binding mechanism has theoretical appeal but limited practical impact.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dchitosan\u0026condition\u003Dhigh\u002Dcholesterol'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

결론

Cochrane review of 14 RCTs: modest total cholesterol reduction (6-14 mg/dL). Clinical significance is debated. Fat-binding mechanism has theoretical appeal but limited practical impact.

Key Study Findings

Other
Therapeutic effects of alpha lipoic acid and/or caffeine-loaded chitosan nanoparticles on memory impairment and neurochemical …
Dose: None vs: None Outcome: Cognitive function 효과: None None

대상 집단: Rat model

Other
Chitosan and solid lipid nanoparticles enhance the efficiency of alpha-lipoic acid against experimental neurotoxicity.
Dose: None vs: None Outcome: Oxidative stress, neuroinflammation, apoptosis 효과: None None

대상 집단: AlCl3-induced neurotoxicity rat model

Key Statistics

14

연구

1100

참여자

Positive

C

등급

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

fatbinding:
1,500-3,000 mg/day before meals
cholesterolsupport:
1,000-3,000 mg/day

상한량: Not formally established; GI side effects at higher doses

연구에서 사용된 용량

용량 기간 효과 N
None -- Positive --
None -- Positive --

권장 복용 시간: 15-30 minutes before meals containing dietary fat

Safety & Side Effects

보고된 부작용

  • Constipation
  • Gas and bloating
  • Nausea
  • Allergic reactions in those with shellfish allergy (contraindicated)

알려진 상호작용

  • Fat-soluble vitamins (A, D, E, K — may reduce absorption)
  • Oral medications (may bind and reduce absorption — separate by 2 hours)
  • Warfarin (may reduce vitamin K absorption, affecting INR)

일일 최대 섭취 허용량: Not formally established; GI side effects at higher doses

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Chitosan help with 고지혈증(이상지질혈증)?
Based on 14 studies with 1,100 participants, there is limited but promising evidence that Chitosan may support 고지혈증(이상지질혈증) management. Our evidence grade is C (Some Evidence).
How much Chitosan should I take for 고지혈증(이상지질혈증)?
Studies have used various dosages. A commonly studied range is 1,500-3,000 mg/day before meals. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Chitosan?
Reported side effects may include Constipation, Gas and bloating, Nausea, Allergic reactions in those with shellfish allergy (contraindicated). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Chitosan and 고지혈증(이상지질혈증)?
We rate the evidence as Grade C (Some Evidence). This rating is based on 14 peer-reviewed studies with 1,100 total participants. The overall direction of effect is positive.

Chitosan 다른 건강 상태에 대한 근거

References

  1. [1] Eman N Hosny et al.. Physiol Behav. 2024. Therapeutic effects of alpha lipoic acid and/or caffeine-loaded chitosan nanoparticles on memory impairment and neurochemical changes in high-fat diet-induced obese … doi:10.1016/j.physbeh.2024.114697 PubMed
  2. [2] Heba H Metwaly et al.. Toxicol Mech Methods. 2022. Chitosan and solid lipid nanoparticles enhance the efficiency of alpha-lipoic acid against experimental neurotoxicity. doi:10.1080/15376516.2021.1998275 PubMed
  3. [3] Norhayati Mohamed Noor et al.. Pharmaceutics. 2020. In Vitro Performance of Dutasteride-Nanostructured Lipid Carriers Coated with Lauric Acid-Chitosan Oligomer for Dermal Delivery. doi:10.3390/pharmaceutics12100994 PubMed

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.